Incidence Rates Table
Area![]() |
Age-Adjusted Incidence Rate† cases per 100,000 (95% Confidence Interval) ![]() |
CI*Rank⋔ (95% Confidence Interval) ![]() |
Average Annual Count![]() |
Recent Trend |
Recent 5-Year Trend‡ in Incidence Rates (95% Confidence Interval) ![]() |
---|---|---|---|---|---|
Alaska 6 | 12.2 (11.1, 13.5) | 42 (23, 48) | 88 |
stable ![]() |
-0.8 (-2.2, 0.7) |
US (SEER+NPCR) 1 | 13.9 (13.9, 14.0) | N/A | 51,518 |
falling ![]() |
-1.9 (-2.3, -1.4) |
Anchorage Municipality 6 | 12.9 (11.0, 15.0) | 3 (1, 5) | 35 |
stable ![]() |
-1.2 (-2.5, 0.4) |
Matanuska-Susitna Borough 6 | 12.0 (9.0, 15.5) | 4 (1, 5) | 12 |
stable ![]() |
-3.7 (-7.5, 0.8) |
Fairbanks North Borough 6 | 14.2 (10.6, 18.6) | 1 (1, 5) | 12 |
stable ![]() |
0.8 (-2.2, 4.6) |
Kenai Peninsula Borough 6 | 13.3 (9.6, 18.0) | 2 (1, 5) | 10 |
stable ![]() |
-0.2 (-4.1, 4.6) |
Juneau City and Borough 6 | 11.6 (6.7, 18.6) | 5 (1, 5) | 4 |
|
|
Aleutians East Borough 6 |
|
|
|
|
|
Aleutians West Census Area 6 |
|
|
|
|
|
Bethel Census Area 6 |
|
|
|
|
|
Bristol Bay Borough 6 |
|
|
|
|
|
Denali Borough 6 |
|
|
|
|
|
Dillingham Census Area 6 |
|
|
|
|
|
Haines Borough 6 |
|
|
|
|
|
Hoonah-Angoon Census Area 6 |
|
|
|
|
|
Ketchikan Gateway Borough 6 |
|
|
|
|
|
Kodiak Island Borough 6 |
|
|
|
|
|
Kusilvak/Wade Hampton Census Area 6 |
|
|
|
|
|
Lake and Peninsula Borough 6 |
|
|
|
|
|
Nome Census Area 6 |
|
|
|
|
|
North Slope Borough 6 |
|
|
|
|
|
Northwest Arctic Borough 6 |
|
|
|
|
|
Petersburg Census Area 6 |
|
|
|
|
|
Prince of Wales-Hyder Census Area 6 |
|
|
|
|
|
Sitka City and Borough 6 |
|
|
|
|
|
Skagway Municipality 6 |
|
|
|
|
|
Southeast Fairbanks Census Area 6 |
|
|
|
|
|
Valdez-Cordova Census Area 6 |
|
|
|
|
|
Wrangell Borough 6 |
|
|
|
|
|
Yakutat City and Borough 6 |
|
|
|
|
|
Yukon-Koyukuk Census Area 6 |
|
|
|
|
|
Notes:
Created by statecancerprofiles.cancer.gov on 05/19/2024 2:50 pm.
Alaska Census Area Name Change: please note that Wade Hampton Census Area, AK (FIPS code=02270) was renamed effective July 1, 2015, and the new name is Kusilvak Census Area (FIPS Code=02158). This website will use Kusilvak/Wade Hampton until the next incidence/mortality data release.
State Cancer Registries may provide more current or more local data.
Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Aleutians East, Aleutians West, Bethel, Bristol Bay, Denali, Dillingham, Haines, Hoonah-Angoon, Ketchikan Gateway, Kodiak Island, Kusilvak/Wade Hampton, Lake and Peninsula, Nome, North Slope, Northwest Arctic, Petersburg, Prince of Wales-Hyder, Sitka, Skagway Municipality, Southeast Fairbanks, Valdez-Cordova, Wrangell, Yakutat City and Borough, Yukon-Koyukuk
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.
^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.
Created by statecancerprofiles.cancer.gov on 05/19/2024 2:50 pm.
Alaska Census Area Name Change: please note that Wade Hampton Census Area, AK (FIPS code=02270) was renamed effective July 1, 2015, and the new name is Kusilvak Census Area (FIPS Code=02158). This website will use Kusilvak/Wade Hampton until the next incidence/mortality data release.
State Cancer Registries may provide more current or more local data.
Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Aleutians East, Aleutians West, Bethel, Bristol Bay, Denali, Dillingham, Haines, Hoonah-Angoon, Ketchikan Gateway, Kodiak Island, Kusilvak/Wade Hampton, Lake and Peninsula, Nome, North Slope, Northwest Arctic, Petersburg, Prince of Wales-Hyder, Sitka, Skagway Municipality, Southeast Fairbanks, Valdez-Cordova, Wrangell, Yakutat City and Borough, Yukon-Koyukuk
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.
^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.